Lung Thoracic Cancer Program

Comprehensive Treatment for Lung and Thoracic Cancers at St. Luke's

Members of Our Team

William R. Burfeind, MD 
Thoracic Surgical Associates of St. Luke's

Matthew M. Puc, MD 
Thoracic Surgical Assoicates of St. Luke's

Yacoub Faroun, MD
St. Luke's Hematology Oncology Specialists

Nicholas M. Cardiges, MD 
Advanced Radiation Oncology Associates

What is it?

Lung cancer is an abnormal growth of cells that originates in the lung. Lung cancer can arise from different types of cells in the lung. The two main types of lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). There are many types of non-small cell lung cancers; these cancers can be discovered at different stages. Approximately 180,000 new cases of lung cancer are diagnosed each year in the United States.

Cancer that starts in another part of the body and spreads to the lung is not considered lung cancer, but metastatic disease caused by another cancer.

Causes, Symptoms & Risk Factors

Lung cancer is commonly associated with smoking or a history of smoking. Exposure to second-hand smoke in your environment can also increase risk for the disease. Exposure to certain substances can also increase risk; these agents include asbestos, chromium, nickel, radon and arsenic. Individuals who suffer from chronic obstructive pulmonary disease (COPD) have an increased risk of developing lung cancer as do those who have a genetic predisposition to cancer.

Tests, Procedures & Treatments

A doctor will perform a physical examination, review symptoms with the patient and perform diagnostic tests that can include:

The treatment of lung cancer depends on several factors, including the location of the cancer, the size of the tumor, whether lymph nodes are involved and a patient's general health.

Treatment options include:

Why Choose St. Luke's?

Coordinated Care from our Experienced Team of Specialists

St. Luke's is committed to leading-edge, efficient and personalized lung cancer care. Patients receive coordinated care from our experienced team of specialists from their first contact with our nurse navigator through the end of their treatment.

All new cases of known or suspected lung cancer are reviewed in a weekly multidisciplinary conference where general thoracic surgeons, pulmonologists, medical oncologists, radiation oncologists, pathologists and radiologists meet to agree upon the optimal treatment plan for each individual patient. Each week, every patient undergoing active lung cancer treatment is reviewed by our Lung Cancer Working Group to assess their progress.

Commitment to Patient-Centered and Research-Driven Care

Whether it is minimally invasive cancer resections, the most up-to-date targeted chemotherapy, or the latest in stereotactic radiation, St. Luke's is committed to patient-centered and research-driven lung cancer care.